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Abstract~Recently we have shown that intracellular low molecular weight (LMW) iron increases during ischemia. It is 
hypothesized that this increase in LMW iron during ischemia underlies the reported hydrogen peroxide toxicity toward ischemic 
hearts. To investigate this hypothesis, rat hearts were subjected to 15 min of no-flow ischemia nd reperfused with buffer 
saturated against 95% N2 and 5% CO2 (anoxic reperfusion) for 7 min. Hearts were then switched to buffer saturated against 
95% 02 and 5% CO2 (reoxygenation) to assess functional recovery. The cardiac function recovered to 80 _ 7% of the preischemic 
value. When the anoxic reperfusion was applied in the presence of 10 #M hydrogen peroxide, functional recovery after 
reoxygenation was 47 _+ 7%. Hearts that were peffused with deferoxamine b fore ischemia nd then subjected to ischemia nd 
anoxic reperfusion i  the presence of 10 #M hydrogen peroxide recovered to 78 _ 8%. Immediate reoxygenation after ischemia 
led to only 45 _ 6% recovery of function. During ischemia, LMW iron increased from 49 _ 45 to 183 +_ 45 pmol/mg protein 
(p < .05) and decreased to 58 +- 38 pmol/mg protein (p < .05) during the subsequent anoxic perfusion. Rat hearts preloaded 
with deferoxamine showed a slightly higher LMW iron content than normal (85 _ 23 and 49 _ 45 pmol/mg protein, respectively; 
n.s.), which showed a small, nonsignificant increase up to 136 _+ 42 pmol/mg protein after 15 min of ischemia. No significant 
changes were found in reduced and oxidized glutathione content and glutathione peroxidase or catalase activities under those 
conditions. Our results indicate that hydrogen peroxide toxicity is determined by the amount of catalytic iron in the LMW pool 
and not by a decrease in antioxidant defense capacity to hydrogen peroxide. 
Keywords--Deferoxamine, Fenton reaction, Anoxic reperfusion, Free radicals 
INTRODUCTION 
In recent years it has been well established that reoxy- 
genation of ischemic tissue leads to the generation of 
reactive oxygen species (ROS). L2 It is likely that those 
ROS contribute to the reperfusion syndrome by damag- 
ing proteins, causing breakage of DNA strands, and 
initiating lipid peroxidation. 2-4 In the presence of a 
catalytic transition metal such as iron, the toxicity of 
the ROS is tremendously increased by the conversion 
of hydrogen peroxide to the highly reactive hydroxyl 
radical. 5
Under physiological conditions, iron is stored or 
contained in proteins in a noncatalytic form. 6 Only a 
very small amount is thought o be present in a low 
molecular weight (LMW) pool 7'8 in a form that has 
been shown to catalyze hydroxyl radical formation. 9-~2 In 
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a recent study from our  laboratory,  13 it has been shown 
that intracellular LMW iron increases dramatically 
during ischemia in isolated rat hearts. In vitro, iron can 
be released from ferritin through a reductive mecha- 
nism, and this release is enhanced by a lower pH. 14 
Therefore, it has been proposed 13that this reallocation 
of iron during ischemia is caused by reducing equiva- 
lents arising during ischemia and that this is greatly 
enhanced by the acidification that occurs in the isch- 
emic hearts. 15 
The role of iron in postischemic free radical toxicity 
has been substantiated by studies in which iron chela- 
tors that inhibit in vitro lipid peroxidation attenuate 
reperfusion injury in a variety of experimental nimal 
models. ~6-~9 However, this has never been studied in 
relation to the amount of catalytic iron in postischemic 
tissue. Shattock et al.20 have shown that ischemic rat 
hearts were much more sensitive to hydrogen peroxide 
than normoxic hearts. This raised the question of 
whether the rise in the intracellular LMW iron pool 
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during ischemia s shown by us underlies the increased 
susceptibility toward hydrogen peroxide. To investi- 
gate this, we have studied hydrogen peroxide toxicity 
in postischemic rat hearts in relation to the LMW iron 
pool and the hydrogen peroxide defense system. 
MATERIALS AND METHODS 
Animals and perfusion protocol 
Twelve- to fourteen-week-old male Wistar rats were 
used. After a brief anaesthesia with diethyl ether, the 
hearts were excised and placed in ice-cold Tyrode 
buffer. The hearts were cannulated through the aorta 
and perfused retrogradely according to Langendorff. 21
Perfusions were carried out at 37°C with Tyrode buffer 
containing 128 mM NaC1, 4.7 mM KC1, 1.25 mM 
CaC12, 20.2 mM NaHCO3, 0.4 mM NaH2PO4, 1 mM 
MgC12, and 11 mM glucose, pH 7.4. The buffer was 
saturated with 95% 02 and 5% CO2. Tyrode buffer 
was made anoxic by saturation with 95% N2 and 5% 
CO2 for at least 1 h. Perfusion pressure was held con- 
stant at 80 cm water pressure. 
Experimental design 
To assess hydrogen peroxide toxicity in the absence 
of superoxide, hearts were subjected to 15 min of warm 
no-flow ischemia and reperfused with anoxic buffer 
either with or without 10 #M hydrogen peroxide for 
7 min. After this anoxic reperfusion, the hearts were 
perfused with oxygenated Tyrode buffer to assess func- 
tional recovery. The effect of iron chelation on this 
insult was investigated by preloading hearts with 50 
#M deferoxamine during a 10-minute perfusion imme- 
diately before ischemia nd addition of 10/~M hydro- 
gen peroxide during the anoxic reperfusion period. 
During ischemia, the hearts were submerged in warm 
(37°C) Tyrode buffer, which was gassed with 95% N2 
and 5% CO2. To assess hydrogen peroxide toxicity 
directly after anoxia, hearts were subjected to 15 min 
of anoxic perfusion, then switched to anoxic buffer 
containing 10 #M hydrogen peroxide for 7 min, and 
compared with hearts that were perfused with anoxic 
buffer for 22 min. 
Catalase, glutathione peroxidase, reduced glutathi- 
one, total glutathione, and LMW iron were determined 
in separate groups of hearts subjected to the appro- 
priate perfusion protocol. 
Functional parameters 
Lactate dehydrogenase (LDH) release in the coro- 
nary effluent, as a measure of tissue damage, and coro- 
nary flow were determined as described earlier, is Apex 
displacement was detected with a smooth muscle trans- 
ducer. Contractility, as a measure of cardiac work, was 
calculated as the product of apex-amplitude and apex- 
frequency, which were recorded every 30 s. Data ac- 
quisition was started after the hearts had shown a stable 
contractility for 10 min. The mean value of the contrac- 
tility of each heart during 10 min before ischemia was 
set at 100%, and subsequent performance was ex- 
pressed as a percentage of preischemic contractility. 
Antioxidant, antioxidant enzymes, and LMW iron 
determinations 
After the appropriate perfusions, hearts were imme- 
diately homogenized toa 10% homogenate in 100 mM 
ice-cold Tris/HC1, pH 7.4. The homogenate was centri- 
fuged at 10.000 g for 15 min. 
Reduced glutathione was determined after protein 
precipitation by 5% trichloric acid of the resulting su- 
pernatant by reduction of 5,5-dithio-bis-2-nitrobenzoic 
acid (DTNB) measured as absorbance at412 nm. Total 
glutathione was determined by the reduction of DTNB 
in the presence of reduced nicotinamide adenine dinu- 
cleotide phosphate (NADPH) and glutathione reduc- 
tase.  22 
Glutathione peroxidase was determined as de- 
scribed elsewhere 23and expressed as units/mg protein 
(1 unit = 1 #mol NADPH/min). Protein concentration 
of the supernatant was determined using Biuret re- 
agents with bovine serum albumin as standard. Cata- 
lase activity was assessed as the disappearance of hy- 
drogen peroxide as determined at240 nm at a hydrogen 
peroxide concentration between 7 and 9 mM and ex- 
pressed as micromoles per minute. 
LMW iron was determined in the supernatant as 
described in detail elsewhere. ~3 
Statistics 
All data are presented as means ___ standard error 
of the mean (SEM). To evaluate differences between 
groups, one-way analysis of variance was performed 
on the data using the Stata release 2.0 (Computing 
Resource Centre, Los Angeles, CA). 
Chemicals 
Unstabilized hydrogen peroxide was obtained from 
Merck (Darmstadt, Germany; MOS selectipure, 
12341) to avoid confounding effects of stabiliser sub- 
stances. Deferoxamine Mesylate (deferoxamine) was 
obtained from Sigma Chemical Co. (St. Louis, MO). 
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Fig. 1. (a) Effect of immediate reoxygenation on the recovery of 
contractility of hearts ubjected to 15 rain of ischemia (open circles) 
and the protective ffect of a period of 7 rain of anoxic reperfusion 
preceding reoxygenation (open triangles). (b) Effect of 10/zM hydro- 
gen peroxide administered uring anoxic reperfusion after ischemia 
on the recovery of function upon reoxygenation (open squares) and 
the protective ffect of preloading with deferoxamine (closed 
squares). Contractility is expressed as percentage of the preischemic 
value. A period of 15 rain of ischemia preceded reperfusion, which 
starts at time zero. Standard errors are omitted for clarity (n = 6 
hearts in each group). 
RESULTS 
Functional recovery and tissue damage 
To study the toxicity of hydrogen peroxide on the 
rat heart, the effect of this compound on cardiac func- 
tion and tissue damage was established under various 
conditions. Rat hearts that were perfused with nor- 
moxic buffer containing 10 #M hydrogen peroxide for 
30 min suffered no loss of contractility or LDH release 
(results not shown). 
Ischemia. Immediate reoxygenation of ischemic hearts 
impaired cardiac function (45 _+ 6% recovery; Fig. 
1A), while a 7-min period of anoxic perfusion preced- 
ing reoxygenation led to a much better (80 ___ 7%) 
restoration of contractility (Fig. 1A). However, if 10 
#M hydrogen peroxide was administered uring this 
anoxic perfusion, a recovery of only 47 _+ 6% was 
found (Fig. 1B). To investigate whether this effect of 
hydrogen peroxide is mediated by an iron-dependent 
mechanism, the hearts were perfused with 50 #M de- 
feroxamine for 10 min before ischemia. Under those 
conditions, the hydrogen peroxide included in the an- 
oxic buffer did not significantly decrease the recovery 
of the contractility (78 ___ 9%, Fig. 1B). 
The susceptibility of the Langendorff rat heart to 
hydrogen peroxide was also studied by the release of 
LDH in the coronary effluent as a parameter of tissue 
damage. Analysis of variance showed that hearts, reox- 
ygenated immediately after 15 min of ischemia, re- 
leased more LDH than hearts that were reperfused for 
the first 7 min after ischemia with anoxic buffer and 
then reoxygenated (Fig. 2A; p < .01). However, if the 
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Fig. 2. (a) Effect of immediate reoxygenation on LDH release in 
the coronary effluent of hearts ubjected to 15 min of ischemia (open 
circles) and the protective effect of 7 min of anoxic reperfusion after 
ischemia preceding reoxygenation (open triangles). (b) Effect of 
10 #M hydrogen peroxide administered uring 7 min of anoxic 
reperfusion after ischemia on the LDH release upon reoxygenation 
(open squares) and the protective effect of preloading with deferoxa- 
mine (closed squares). Reperfusion starts at time zero. (Means _+ 
SEM, n = 6 hearts in each group.) 
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Fig. 3. Effect of reoxygenation contractility after 22 min of anoxic 
perfusion of hearts perfused without (open circles) or with (closed 
circles) 10 #M hydrogen peroxide present during the last 7 min of 
anoxia. A period of 15 min of anoxic perfusion (time = -15 to 0) 
preceded anoxic perfusion with or without hydrogen peroxide (time 
= 0 to 7). After 7 min, the hearts were reoxygenated (time = 7 and 
onward). Means of five hearts per group; standard errors are omitted 
for clarity. 
anoxic buffer contained 10 #M hydrogen peroxide, the 
LDH in the coronary effluent increased significantly 
(Fig. 2B; p < .01 compared to anoxia without hydro- 
gen peroxide, Fig. 2A). The increased release of LDH 
was prevented by preloading of the hearts with defer- 
oxamine (Fig. 2B; p < .01, for the difference in the 
absence of deferoxamine). 
Anoxia. To investigate whether the toxicity depends 
on a preceding period of ischemia, hydrogen peroxide 
toxicity was assessed after 15 min of anoxic perfusion. 
The results showed that hydrogen peroxide present 
during the last 7 min of a period of 22 min of anoxia 
did not impair the contractility of the reoxygenated 
hearts compared to the hearts subjected to anoxic per- 
fusion without hydrogen peroxide (94 _+ 5 and 96 _+ 
4%, respectively, Fig. 3). In the coronary effluent from 
these hearts, very little LDH was detectable (<0.05 
mU/g wet weight/min). Furthermore, we have shown 
earlier that reoxygenation after anoxic perfusion did 
not lead to any loss of contractility and that LMW iron 
does not increase under those conditions) 3 
Low molecular weight iron 
Because deferoxamine pretreatment abolished hy- 
drogen peroxide toxicity after ischemia, the amount of 
iron in the LMW pool was determined under the vari- 
ous conditions (Fig. 4). During ischemia the amount 
of iron in the LMW pool increased from 49 _+ 16 to 
183 _+ 45 pmol/mg protein (p < .05), confirming our 
earlier findings. ~3 Upon reperfusion with anoxic buffer 
in the presence or absence of hydrogen peroxide, the 
LMW iron pool returned to about normal values over 
the next 7 min (22 _+ 18 and 59 +_ 29 pmol/mg protein, 
respectively; p < .05) and remained fairly constant 
after reoxygenation. Hearts preloaded with deferoxa- 
mine showed a slightly higher LMW iron content than 
normal (85 _+ 23 and 49 _+ 45 pmol/mg protein, respec- 
tively; n.s.), but ischemia did not lead to a significant 
increase of LMW iron in those hearts (136 _+ 42 pmol/ 
mg protein after 15 rain; n.s.). Anoxic perfusion for 
15 min did not cause a significant change in LMW 
iron, and neither did the additional 7 rain of anoxic 
reperfusion in the presence of hydrogen peroxide. (61 
_+ 29, 55 _+ 32, and 42 +_ 25 pmol/mg protein respec- 
tively, n.s.). 
Antioxidant defense system 
Besides a role of LMW iron, it is possible that the 
increased susceptibility of the (post-)ischemic heart to 
hydrogen peroxide is caused by a decrease in the hy- 
drogen peroxide metabolizing enzymes (i.e., catalase 
and glutathione peroxidase). A decrease of reduced 
glutathione, the substrate of the latter antioxidant en- 
zyme, will also lead to impaired detoxification of hy- 
drogen peroxide. Therefore, the activities of catalase 
and glutathione peroxidase, and the total glutathione 
and reduced glutathione content, were determined un- 
der the various conditions. Because hydrogen peroxide 
had no effect after a period of anoxia, these parameters 
were not determined in these hearts. Table 1 shows 
that the antioxidant defense system did not vary sig- 
nificantly between all groups (one-way analysis of 
variance, using the Bonferonni correction for multiple 
comparisons). 
DISCUSSION 
The main conclusion to be drawn from the present 
study is that the increased susceptibility to hydrogen 
peroxide of the postischemic heart is related to the 
amount of catalytic LMW iron and not due to a de- 
crease in hydrogen peroxide metabolizing capacity. 
Our data showed that a short period of anoxic reper- 
fusion after ischemia causes a much better ecovery of 
the contractility compared to immediate reoxygena- 
tion. Previously, the beneficial effect of hypoxic reper- 
fusion was attributed to a decrease in the production 
of ROS during reoxygenation. 24 However, others have 
shown that after a short period of anoxic reperfusion, 
a burst of free radicals occurs during reoxygenation, 
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Fig. 4. The effect of anoxic reperfusion on LMW iron in hearts reperfused with anoxic Tyrode for the first 7 min after ischemia 
either without hydrogen peroxide (control), with 10/~M hydrogen peroxide (H202), or with hydrogen peroxide and deferoxamine 
pretreatment (DFX + H202). Hearts were homogenized as described after normoxic perfusion (normoxic), 15 min of ischemia 
(ischemic), 15 min of ischemia nd 7 min anoxic reperfusion (+7 min anox), or after 15 min ischemia + 7 min anoxic reperfusion 
+ 3 min reoxygenation (+3 min reox). Note that the first two groups in the control and the H202 group are identical. (* denotes 
p < .05 vs. normoxic hearts, # denotes p < .05 vs. ischemic hearts in that group, means ___ SEM, n = 5 in each group.) 
which is of similar magnitude to the burst that occurs 
during immediate reoxygenation. I  that study, no radi- 
cals were observed uring the anoxic reperfusion pe- 
riod. 25 In the present study, we have shown that during 
the anoxic reperfusion period the LMW iron pool, 
which was increased uring ischemia, returned to val- 
ues that did not differ from normoxic hearts. Appar- 
ently, under those conditions the amount of free iron 
became too low to catalyze the formation of hydroxyl 
radicals in sufficient amounts to cause tissue damage 
upon reoxygenation. This hypothesis is substantiated 
by our finding that hydrogen peroxide was only toxic 
when the LMW pool was increased. The presence of 
deferoxamine did not affect he magnitude of the LMW 
iron pool at the end of ischemia (183 ___ 45 versus 136 
___ 42 pmol/mg protein, p = n.s.). During ischemia in 
the absence of deferoxamine, the released iron will be 
chelated to the natural chelators of the LMW pool, in 
Table 1. Hydrogen Peroxide Specific Defenses in Rat Hearts Perfused with Normoxic Buffer (Normoxic) 
for 15 Min, after 15 Min of No Flow Ischemia (15' Ischemia), after 7 Min of Anoxic Reperfusion (+7' 
N2), and after the Subsequent 3 Min of Reoxygenation (+3' 02) 
Normoxic 15' Ischemia +7 min N2 +3'  O2 
Glutathione peroxidase /~mol NADPH per minute 
Controls 106.0 ± 18.0 172.0 ± 44.0 174.0 ___ 34.0 168.0 _+ 40.0 
H202 106.0 ± 18.0 172.0 _ 44.0 186.0 ± 38.0 175.0 _+ 35.0 
DFX + H202 164.0 ± 45.0 136.0 ± 36.0 195.0 ± 65.0 183.0 _+ 59.0 
Catalase #mol H202 per minute 
Controls 20.9 ___ 2.4 27.1 ± 5.5 24.1 ___ 4.0 22.7 ± 6.1 
H202 20.9-4- 2.4 27.1 _+ 5.5 29.3 ± 5.5 26.2 _+ 5.2 
DFX + H~O2 16.9 _+ 5.4 19.5 _ 4.7 22.7 ___ 5.1 27.6 ___ 4.0 
Reduced glutathione nmol per mg protein 
Controls 16.6 - 3.2 20.3 _ 5.4 25.5 -4- 5.2 17.8 ___ 5.0 
H202 16.6 ± 3.2 20.3 ± 5.4 25.4 _ 1.8 16.2 ± 3.1 
DFX + H202 21.8 ± 5.4 18.5 _+ 4.2 26.8 __+ 5.1 18.1 ± 1.3 
Total glutathione nmol per mg protein 
Controls 14.4 ± 3.6 28.9 _+ 5.1 24.4 __. 3.9 18.8 _ 3.9 
H202 14.4 ± 3.6 28.9 ± 5.1 16.1 _ 1.9 15.8 ___ 5.1 
DFX + H202 19.1 ± 4.1 16.8 _+ 2.4 20.3 ± 3.4 10.5 ___ 1.2 
Control hearts (control) were perfused with Tyrode only. H202: Hearts that were reperfused with anoxic 
Tyrode containing 10 #M H202. DFX + H202: Hearts that were perfused with normoxic Tyrode containing 
50 lzM deferoxamine during 10 min before ischemia nd repeffused with anoxic Tyrode containing 10 #M 
H202. 
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which form it is avai lable to catalyse the Haber -Weiss  
reactions. However ,  in the presence of  deferoxamine 
the released iron wil l  be chelated as ferr ioxamine,  
which does not catalyse these reactions. Smith et al. 
have shown that the protect ive f fect  of  deferoxamine 
indeed depends on iron chelat ion, since the protect ion 
is lost when an equ imolar  amount  of  fer r ioxamine is 
used. 16 In the present study, hearts could cope with 
hydrogen peroxide immediate ly  after ischemia only i f  
the released iron had been rendered noncatalyt ic  by 
the iron chelator deferoxamine.  Therefore,  we con- 
c lude that hydrogen peroxide is toxic after ischemia 
due to an i ron-dependent  mechanism.  
How the drop in the LMW iron pool  during anoxic 
reperfusion occurred is not known,  but it is conce ivab le  
that the free iron was washed out. Calculat ion showed 
that approx imate ly  10 nmol  of  iron were lost. This is 
so little that it cannot be determined if  di luted in the 
coronary effluent. Reuptake o f  iron by ferrit in is not 
very l ikely because this process is oxygen dependent.  26
Normal ly ,  hydrogen peroxide is detoxif ied effec- 
t ively by the ant ioxidant enzymes  catalase and glutathi-  
one peroxidase,  but i f  the oxygen supply is suddenly 
increased after an ischemic  per iod the format ion of  
ROS may overwhe lm the ant ioxidant enzyme system. 
Under  such a condit ion and if  accompanied  by an in- 
creased amount  of  ferrous iron in the LMW iron pool, 
hydrogen peroxide is immediate ly  converted to the 
highly react ive hydroxyl  radical, leading to loss of  car- 
diac funct ion and tissue damage.  
F rom a cl inical point of  v iew,  our results indicate 
that it may be benefic ial  to flush an ischemic organ with 
anoxic buffer  or venous b lood before reoxygenat ion,  
because this could lead to normal ized levels of  LMW 
iron and attenuation of  reperfus ion injury without the 
need for pharmacolog ica l  interventions. 
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